Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01796080
Other study ID # PAF_V1.1 (05.07.2012)
Secondary ID
Status Completed
Phase N/A
First received February 18, 2013
Last updated December 20, 2013
Start date October 2012
Est. completion date December 2013

Study information

Verified date December 2013
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Interventional

Clinical Trial Summary

In this randomised controlled cross-over study we will investigate whether intrathoracic pressure changes induced by simulated obstructive apnoea and hypopnoea trigger premature supraventricular and ventricular contractions as well as atrial fibrillation in patients with paroxysmal atrial fibrillation.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion criteria:

- Age 18-75 years

- History of ECG-documented paroxysmal atrial fibrillation within the last 12 months and currently in sinus rhythm

- Informed consent

Exclusion criteria:

- Mental or physical disability precluding informed consent or compliance with the protocol

- Amiodarone or Dronedarone medication

- Previous radiofrequency ablation for atrial fibrillation

- Severe structural heart disease

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
Mueller manoeuvre

Inspiratory threshold

Expiratory apnoea

Steady state normal breathing


Locations

Country Name City State
Switzerland University Hospital Zurich, Division of Pneumology Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of subjects with premature myocardial contractions and/or atrial fibrillation 20 seconds No
Secondary ECG-derived myocardial de- and repolarization times 20 seconds No